SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2018 San Mateo, CA
Activity/Course #:
: 10.13.18PC
Cost:
: Free
Release/Start Date:
: Oct 13 2018
Expiration Date:
: Oct 13 2019
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.50 hours
Credit(s):
: 7.50 AMA PRA Category I Credit(s)
7.50 AANP Contact hour(s) which includes 3.25 pharmacology hour(s)
Hardware/Software Requirements:
Saturday, October 13, 2018
San Mateo Marriott San Francisco Airport
1770 S. Amphlett Blvd
San Mateo, CA 94402
(650) 653-6000

Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
Complimentary self-parking is available at the hotel.


Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.
Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives

At the conclusion of this program, participants should be able to:

1. Recognize the importance of early identification of patients with potential idiopathic pulmonary fibrosis (IPF); Utilize appropriate strategies to diagnose a patient with IPF while excluding other potential mimickers; Discuss the available therapeutic options for patients with IPF; Recognize the role of the primary care clinician in managing the multi-morbidities associated with IPF.

2. Describe the impact of nocturia on affected patients; Evaluate symptoms of nocturia in affected patients; Assess current pharmacologic and nonpharmacologic nocturia management strategies; Differentiate the mechanisms of action and safety and efficacy profiles of available and emerging therapies for nocturia.

3. Review the epidemiology of primary biliary cholangitis (PBC); Describe the pathophysiology of PBC; Recognize how to evaluate a patient for PBC; Discuss the treatment of PBC, including the treatment of extrahepatic manifestations.

4. Describe the findings from recent trials of PCSK9i hypercholesterolemia treatments on cardiovascular outcomes; Discuss current guidelines and recommendations on the management of hyperlipidemia in high risk patients; Incorporate current data into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Recognize barriers to access for PCSK9 monoclonal antibody therapy and discuss novel strategies to overcome them.

5. Identify the barriers between clinicians and patients to discussing and initiating earlier insulin therapy for diabetes management; Discuss currently available basal and ultrabasal insulins and their pharmacokinetic/ pharmacodynamic profiles Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Describe how best to initiate, utilize and intensify insulin therapy in patients with diabetes while incorporating treatment guidelines and unique patient needs; Integrate strategies to improve the patient experience with, and adherence to, insulin therapy.

6. Utilize evidence-based strategies to diagnose patients presenting with headache; Identify associated conditions (e.g. depression), and red flags for potentially life-threatening causes of headache; Use evidence-based recommendations to prescribe treatment for patients presenting with acute or emergent headache pain; Develop collaborate management plans, emphasizing patient education on avoiding triggers that cause headache, and adherence to prescribed treatment strategies; Discuss newer pharmacologic targets for managing patients with chronic migraine.

 

Agenda *

 7:30-8:00 Continental Breakfast and Registration
 8:00-8:10 Welcome Remarks
Marlene R. Wolf, MD, FAAFP
 8:10-9:20 Navigating the Maze of Interstitial Lung Disease: Improving Outcomes through Early Diagnosis
Kevin Flaherty, MD, MS
 9:20-10:30 Management of Nocturia: An Unmet Need in LUTS
Matt T. Rosenberg, MD
 10:30-10:50 Break
10:50-12:00
 Recognition and Management of Primary Biliary Cholangitis (PBC): A Chronic Inflammatory Liver Disease
Kalyan Ram Bhamidimarri, MD, MPH
12:00-1:00
 Lunch
1:00-2:10
 Managing Lipids and Cardiovascular Risk: Using the Data to Optimize Care
Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH
2:10-3:40
 Getting Comfortable with Insulin: New Approaches to Getting Patients Safely to Target
Jeff Unger, MD, FAAFP, FACE
3:40-3:50
 Break
3:50-5:00
 Managing Migraine: Primary Care for Primary Headaches
Jeff Unger, MD, FAAFP, FACE
5:00-5:05
 Closing Remarks
Marlene R. Wolf, MD, FAAFP

* Agenda subject to change

 

Faculty

Kalyan Ram Bhamidimarri, MD, MPH
Transplant Hepatologist, University of Miami
Medical Director of Small Bowel & Multi-visceral Transplantation
Miami Transplant Institute
Miami, FL

Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASH
Professor of Medicine, Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA

Kevin Flaherty, MD, MS
Professor in Pulmonary and Critical Care Medicine
University of Michigan
Ann Arbor, MI

Marlene R. Wolf, MD, FAAFP
Clinical Assistant Professor of Family Medicine
Nova Southeastern University's College of Allopathic Medicine
Family Practice
Lifetime Medical Consulting, LLC
Coral Springs, FL

Matt T. Rosenberg, MD
Director, Mid-Michigan Health Centers
Jackson, MI

Jeff Unger, MD, FAAFP, FACE
Assistant Clinical Professor of Family Medicine
UC Riverside School of Medicine
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, CA


Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer
Association of Black Cardiologists
New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7.50 contact hours of continuing education, which includes 3.25 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This educational activity is supported, in part, by educational funding provided by Amgen; an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.; an educational grant from Ferring Pharmaceuticals, Inc.; an educational grant from Sanofi US; an educational grant from Sanofi US and Regeneron Pharmaceuticals; and an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.